rs186898202

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7

The NM_001039876.3(SYNE4):​c.1020G>A​(p.Glu340Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000858 in 1,613,252 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00079 ( 1 hom., cov: 31)
Exomes 𝑓: 0.00087 ( 0 hom. )

Consequence

SYNE4
NM_001039876.3 synonymous

Scores

1
1
13

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.206

Publications

1 publications found
Variant links:
Genes affected
SYNE4 (HGNC:26703): (spectrin repeat containing nuclear envelope family member 4) This gene is a member of the nesprin family of genes, that encode KASH (Klarsicht, Anc-1, Syne Homology) domain-containing proteins. In addition to the KASH domain, this protein also contains a coiled-coil and leucine zipper region, a spectrin repeat, and a kinesin-1 binding region. This protein localizes to the outer nuclear membrane, and is part of the linker of nucleoskeleton and cytoskeleton (LINC) complex in the nuclear envelope. LINC complexes are formed by SUN (Sad1, UNC-84)-KASH pairs, and are thought to mechanically couple nuclear components to the cytoskeleton. Mutations in this gene have been associated with progressive high-frequency hearing loss. The absence of this protein in mice also caused hearing loss, and changes in hair cell morphology in the ears. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
SYNE4 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 76
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011614025).
BP6
Variant 19-36003624-C-T is Benign according to our data. Variant chr19-36003624-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 504814.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.206 with no splicing effect.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SYNE4NM_001039876.3 linkc.1020G>A p.Glu340Glu synonymous_variant Exon 7 of 8 ENST00000324444.9 NP_001034965.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SYNE4ENST00000324444.9 linkc.1020G>A p.Glu340Glu synonymous_variant Exon 7 of 8 5 NM_001039876.3 ENSP00000316130.3

Frequencies

GnomAD3 genomes
AF:
0.000789
AC:
120
AN:
152170
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00236
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000999
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000797
AC:
197
AN:
247220
AF XY:
0.000879
show subpopulations
Gnomad AFR exome
AF:
0.000328
Gnomad AMR exome
AF:
0.00111
Gnomad ASJ exome
AF:
0.0000999
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00136
Gnomad NFE exome
AF:
0.00102
Gnomad OTH exome
AF:
0.00166
GnomAD4 exome
AF:
0.000865
AC:
1264
AN:
1460964
Hom.:
0
Cov.:
31
AF XY:
0.000846
AC XY:
615
AN XY:
726644
show subpopulations
African (AFR)
AF:
0.000299
AC:
10
AN:
33472
American (AMR)
AF:
0.00103
AC:
46
AN:
44612
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26104
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85886
European-Finnish (FIN)
AF:
0.00124
AC:
66
AN:
53352
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5764
European-Non Finnish (NFE)
AF:
0.000965
AC:
1073
AN:
1111704
Other (OTH)
AF:
0.00113
AC:
68
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
73
146
219
292
365
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000788
AC:
120
AN:
152288
Hom.:
1
Cov.:
31
AF XY:
0.000806
AC XY:
60
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41548
American (AMR)
AF:
0.00235
AC:
36
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.000941
AC:
10
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00100
AC:
68
AN:
68026
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000810
Hom.:
0
Bravo
AF:
0.000918
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000752
AC:
3
ESP6500EA
AF:
0.00108
AC:
9
ExAC
AF:
0.000744
AC:
90
EpiCase
AF:
0.000872
EpiControl
AF:
0.00125

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 27, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Aug 04, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Glu340Glu in exon 7 of SYNE4: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 0.1% (68/57658) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.bro adinstitute.org; dbSNP rs186898202). -

SYNE4-related disorder Benign:1
Aug 29, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.16
CADD
Benign
2.5
DANN
Benign
0.92
DEOGEN2
Benign
0.14
T
Eigen
Benign
-0.17
Eigen_PC
Benign
-0.38
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.32
T
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-0.76
T
PhyloP100
0.21
PROVEAN
Uncertain
-4.2
D
REVEL
Benign
0.11
Sift
Pathogenic
0.0
D
Polyphen
1.0
D
MutPred
0.29
Loss of catalytic residue at G281 (P = 0.0429);
MVP
0.57
ClinPred
0.088
T
GERP RS
1.4
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs186898202; hg19: chr19-36494526; API